Clinical trials
Urologic Diseases trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
79 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2010 | 3 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 3 |
| 2014 | 1 |
| 2015 | 9 |
| 2016 | 3 |
| 2017 | 5 |
| 2018 | 6 |
| 2019 | 6 |
| 2020 | 8 |
| 2021 | 6 |
| 2022 | 9 |
| 2023 | 7 |
| 2024 | 2 |
| 2025 | 3 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 36 |
| Terminated | 13 |
| Recruiting | 10 |
| Active, not recruiting | 9 |
| Unknown status | 5 |
| Enrolling by invitation | 3 |
| Not yet recruiting | 1 |
| Suspended | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 5 |
| Allena Pharmaceuticals | 4 |
| Northwestern University | 3 |
| Bright Uro | 2 |
| Celldex Therapeutics | 2 |
| Coloplast A/S | 2 |
| Cook MyoSite | 2 |
| Goldfinch Bio, Inc. | 2 |
| Loma Linda University | 2 |
| Rainier Therapeutics | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Urologic Diseases | 79 |
| Kidney Diseases | 24 |
| Urinary Bladder Diseases | 12 |
| Urinary Incontinence | 10 |
| Glomerulonephritis | 9 |
| Glomerulonephritis, IGA | 9 |
| Lower Urinary Tract Symptoms | 9 |
| Urinary Bladder Neoplasms | 9 |
| Urinary Bladder, Overactive | 9 |
| Urologic Neoplasms | 9 |
Trials
Showing 1 to 25 of 79. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.